TET2 mutation

Papers on TET2 mutation

62 papers11 new in 30 days

Wednesday, November 18

Monday, November 9

Saturday, November 7

AHA Scientific Sessions 2026 Abstract

Blood-cell mutations linked to later coronary disease

Over 10 years, the hazard ratio—a comparison of disease rates over time—was 1.61 for participants with the condition versus those without it.Over 10 years, the hazard ratio—a comparison of disease rates over time—was 1.61 for participants with the condition versus those without it.

A plaque-narrowed coronary artery beside an open artery, surrounded by blood cells with dark nuclear marks clustered near the narrowed vessel.
Cohort · 28,312 peopleBiomarkers

Friday, October 30

Wednesday, October 28

Monday, October 26

ESC Congress 2026 Abstract

Blood mutations linked to heart, kidney, and metabolic disease

Participants with age-related expansion of mutated blood cells had an adjusted hazard ratio of 1.11 for progression to syndrome stage 4 compared with participants without…Participants with age-related expansion of mutated blood cells had an adjusted hazard ratio of 1.11 for progression to syndrome stage 4 compared with participants without the condition.

Blood cells cluster densely beside a thick-walled heart and scarred kidney, while fewer cells sit near smaller, intact heart and kidney sections.

Thursday, October 22

bioRxiv

Some preleukemic cells suppress normal neighbors in culture

About 10% of preleukemic mutant clones actively suppressed or completely eliminated competing normal cells in a laboratory culture model.About 10% of preleukemic mutant clones actively suppressed or completely eliminated competing normal cells in a laboratory culture model.

Single-cell split cultures are phenotypically, functionally and molecular homogeneous.
Preprint: animal cell studyMechanisms

Thursday, October 15

Wednesday, October 14

Nature Communications

TET2 loss alters DNA copying during drug treatment in cells

Lab experiments showed that Olaparib treatment lengthened copied DNA tracts, increased DNA breaks and heightened drug sensitivity in cells lacking TET2, but not DNMT3A.Lab experiments showed that Olaparib treatment lengthened copied DNA tracts, increased DNA breaks and heightened drug sensitivity in cells lacking TET2, but not DNMT3A.

Loss of TET2, but not DNMT3A, increases fork progression and DNA damage in PARPi-treated cells.
Human cell studyTET2

Thursday, October 8

Wednesday, October 7

HemaSphere

Blood-cell mutation patterns linked to cancer progression

A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.

Figure from HemaSphere
Cohort study of 256 peopleCancer

Monday, October 5

Thursday, October 1

medRxiv

ASXL1-mutant clonal hematopoiesis links to aortic valve disease

In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or IL-6 inhibition.In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or IL-6 inhibition.

Multivariable-adjusted associations of CHIP and key CHIP subtypes with incident aortic stenosis in the UK Biobank Forest plot of hazard ratios for risk of incident aortic stenosis by CHIP status in…
Preprint: cohort study of 449,109 peopleASXL1

Wednesday, September 30

Thursday, September 24

Thursday, September 10

Wednesday, August 26

Friday, July 17

Wednesday, June 17

Wednesday, May 27

Friday, May 1

Wednesday, April 15

Sunday, March 8

Wednesday, February 18

Monday, February 16